{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:10:02Z","timestamp":1760037002714,"version":"build-2065373602"},"reference-count":14,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Amyloidosis is characterized by the tissue deposition of insoluble fibrils derived from misfolded proteins. This case report describes a Hispanic man diagnosed with both monoclonal gammopathy of undetermined significance (MGUS) and wild-type transthyretin amyloidosis (ATTR) cardiac amyloidosis. The diagnosis was made using a combination of serological tests and multimodality cardiac imaging. The report highlights the importance of multimodality imaging in diagnosing cardiac amyloidosis, especially in cases where MGUS is also present. The patient presented with shortness of breath and was found to have cardiac abnormalities through electrocardiogram, echocardiogram, and cardiac magnetic resonance (CMR). A technetium-99m pyrophosphate (Tc-99m PYP) scan confirmed the presence of ATTR cardiac amyloidosis. Bone marrow biopsy confirmed MGUS. The patient was treated with diuretics and remained asymptomatic during follow-up. The report emphasizes the need for accurate diagnosis to differentiate between AL, ATTR, and MGUS due to their distinct clinical courses and treatments.<\/jats:p>","DOI":"10.3390\/life15101493","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T10:27:53Z","timestamp":1758623273000},"page":"1493","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodality Imaging in Monoclonal Gammopathy of Undetermined Significance and ATTR Wild-Type Cardiac Amyloidosis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5805-1810","authenticated-orcid":false,"given":"Amalia","family":"Peix","sequence":"first","affiliation":[{"name":"Institute of Cardiology and Cardiovascular Surgery, La Habana 10400, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9990-9844","authenticated-orcid":false,"given":"Aylen","family":"Perez","sequence":"additional","affiliation":[{"name":"Institute of Cardiology and Cardiovascular Surgery, La Habana 10400, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3622-384X","authenticated-orcid":false,"given":"Yrving","family":"Figueredo","sequence":"additional","affiliation":[{"name":"Clinica Central Cira Garcia, La Habana 10400, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonel","family":"Torres","sequence":"additional","affiliation":[{"name":"Isotopes Center, La Habana 10200, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8842-7911","authenticated-orcid":false,"given":"Lazaro O.","family":"Cabrera","sequence":"additional","affiliation":[{"name":"Institute of Cardiology and Cardiovascular Surgery, La Habana 10400, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselle","family":"Monzon","sequence":"additional","affiliation":[{"name":"National Center for Medical Genetics, La Habana 10300, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5895-8057","authenticated-orcid":false,"given":"Hilda","family":"Roblejo","sequence":"additional","affiliation":[{"name":"National Center for Medical Genetics, La Habana 10300, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Perera","sequence":"additional","affiliation":[{"name":"Isotopes Center, La Habana 10200, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-2379","authenticated-orcid":false,"given":"Anita","family":"Brink","sequence":"additional","affiliation":[{"name":"Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Paez","sequence":"additional","affiliation":[{"name":"Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"H544","DOI":"10.1152\/ajpheart.00815.2011","article-title":"Current perspectives on cardiac amyloidosis","volume":"302","author":"Guan","year":"2012","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40119-021-00222-w","article-title":"Multidisciplinary Approaches for Transthyretin Amyloidosis","volume":"10","author":"Koike","year":"2021","journal-title":"Cardiol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Danilov, A., D\u2019Angelo, L., Marsela, E., Costabel, J.P., Jorde, U.P., and Rochlani, Y. (2025). Transthyretin cardiac amyloidosis: Advances and ambiguities. Heart Fail. Rev., 1\u201312.","DOI":"10.1007\/s10741-025-10552-9"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar Technetium 99m pyrophosphate cardiac imaging: Predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41408-021-00483-7","article-title":"Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021","volume":"11","author":"Sidiqi","year":"2021","journal-title":"Blood Cancer J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/13506129.2018.1436048","article-title":"Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)","volume":"25","author":"Phull","year":"2018","journal-title":"Amyloid"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101853","DOI":"10.1016\/j.jocmr.2025.101853","article-title":"Society for Cardiovascular Magnetic Resonance reference values (\u201cnormal values\u201d) in cardiovascular magnetic resonance: 2025 update","volume":"27","author":"Hetzel","year":"2025","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1007\/s12350-021-02857-7","article-title":"Volumetric evaluation of 99mTc-pyrophosphate SPECT\/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters","volume":"29","author":"Watanabe","year":"2022","journal-title":"J. Nucl. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11899-010-0047-9","article-title":"Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"5","author":"Kyle","year":"2010","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41408-019-0193-9","article-title":"Two types of amyloidosis presenting in a single patient: A case series","volume":"9","author":"Sidiqi","year":"2019","journal-title":"Blood Cancer J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"104878","DOI":"10.1016\/j.jaccas.2025.104878","article-title":"Concurrent TTR and AL Amyloidosis: Diagnostic challenges and clinical implications","volume":"30","author":"Wats","year":"2025","journal-title":"JACC Case Rep."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/10\/1493\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:47:36Z","timestamp":1760035656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/10\/1493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":14,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["life15101493"],"URL":"https:\/\/doi.org\/10.3390\/life15101493","relation":{},"ISSN":["2075-1729"],"issn-type":[{"type":"electronic","value":"2075-1729"}],"subject":[],"published":{"date-parts":[[2025,9,23]]}}}